期刊文献+

PI3K基因在甲状腺腺瘤组织中的表达及其意义

Expression and role of phosphatidylinositol 3-kinase gene in thyroid adenoma
下载PDF
导出
摘要 目的:分析PI3K基因在人甲状腺腺瘤组织与瘤旁组织中mRNA的表达差异,探讨基因PI3K表达与甲状腺腺瘤疾病之间的关系。方法:外科手术中获取19例单发结节型甲状腺腺瘤组织及瘤旁组织,采用RT-PCR技术检测腺瘤及瘤旁组织中PI3K基因的表达水平。结果:甲状腺腺瘤组织中PI3K基因的表达水平为(77.69±14.17)%,瘤旁组织中表达水平为(43.84±18.14)%,甲状腺腺瘤组织中PI3K基因的表达水平显著高于瘤旁组织(P<0.001)。结论:甲状腺腺瘤组织中PI3K基因表达显著上调,PI3K信号转导途径的功能异常可能与甲状腺腺瘤发生发展的机制有关。 Objective:To analyze the difference in the phosphatidylinositol 3-kinase(PI3K) gene expression between human thyroid adenoma tissue and normal peri-tumor thyroid tissue. To explore the relationship between PI3K gene expression and thyroid adenoma. Methods:Thyroid adenoma tissue specimens were obtained from 19 patients with single adenomas in surgical procedure. Normal peri-tumor thyroid tissue from the 19 patients served as control. The RT-PCR technique was used to detect the level of PI3K gene expression. Results:The mRNA expression level of PI3K gene in thyroid adenoma tissue was(77.69 ± 14.17)%, while in normal peri-tumor thyroid tissue was 43.84 ± 18.14%. The level of PI3K gene expression in thyroid adenoma was significantly higher than that in normal peri-tumor thyroid tissue(P < 0.001). Conclusion:PI3K gene was significantly up-regulated in the tumor tissues of thyroid adenoma. The activated PI3K signaling pathway might have an important role in the pathogenesis of thyroid adenoma.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第6期398-400,共3页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省教育厅自然科学(01KJD320007)
关键词 PI3K基因 信号分子 甲状腺腺瘤 PI3K signaling molecule thyroid adenoma
  • 相关文献

参考文献8

  • 1Zingg D, Riesterer O, Fabbro D, et al. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells [J]. Cancer Res, 2004,64 (15):5398-5406.
  • 2Cantley LC. The phosphoinositide 3-kinase pathway [J].Science, 2002,296(5573): 1655-1657.
  • 3Leenders F, Mopert K, Schmiedeknecht A, et al. PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase[J]. EMBO J,2004,23(16) :3303-3313.
  • 4Radisavljevic Z. Locus of fragility in robust breast cancer system[J]. J Cell Biochem,2004,92(5): 1020-1024.
  • 5Deleu S, Allory Y, Radulescu A, et al. Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology [J]. Thyroid,2000,10 (2):131-140.
  • 6Gire V, Marshall C, Mynford-Thomas D. PI-3-kinase is an essential anti-apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS[J]. Oncogene, 2000,19 (19): 2269-2276.
  • 7Bell A, Gagnon A, Dods P, et al. TSH signaling and cell survival in 3T3-L1 preadipocytes [J]. Am J Physiol Cell Physiol, 2002,283 (4): C1056-1064.
  • 8Suh JM, Song JH, Kim DW, et al. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B,FRAP/mammalian target of rapamycin, and ribosomal S6kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland [J]. J Biol Chem,2003,278 (24) :21960-21971.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部